Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-EN Version v2-FR
Language English French
Date Updated 2019-04-25 2017-08-18
Drug Identification Number 00511552 00511552
Brand name SANDOMIGRAN DS SANDOMIGRAN DS
Common or Proper name Sandomigran Sandomigran
Company Name PALADIN PHARMA INC. PALADIN PHARMA INC.
Ingredients PIZOTIFEN PIZOTIFEN
Strength(s) 1MG 1MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100 tablets 100 tablets
ATC code N02CX N02CX
ATC description ANTIMIGRAINE PREPARATIONS ANTIMIGRAINE PREPARATIONS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2019-04-24 2019-11-29
Actual start date
Estimated end date Unknown
Actual end date 2019-04-24
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments Avoided backorder
Health Canada comments